Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)

Vaccine. 1989 Oct;7(5):465-73. doi: 10.1016/0264-410x(89)90164-3.

Abstract

In mice, immunostimulatory complexes (ISCOMs) prepared from HIV-1 B external envelope glycoprotein (gp120) induced 10-fold higher antibody titres than gp120 emulsified in depot adjuvant, as measured by enzyme-linked immunosorbent assay (ELISA). Rhesus monkeys immunized with gp120 ISCOMs produced precipitating and virus neutralizing antibody titres equivalent to those seen in HIV-infected chimpanzees and humans. After multiple immunizations with HIV-1 B gp120 ISCOMs, a rhesus monkey developed a neutralizing response to the HIV-1 isolates RF and MN, but not to the CC isolate. Antisera from ISCOM-immunized rhesus monkeys recognized gp120 on the membranes of HIV-1 B-infected H9 cells, indicating the preservation of epitope structure in the ISCOMs matrix.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic*
  • Animals
  • Blotting, Western
  • Centrifugation, Density Gradient
  • Chromatography, Affinity
  • Electrophoresis, Polyacrylamide Gel
  • Enzyme-Linked Immunosorbent Assay
  • HIV Antibodies / biosynthesis*
  • HIV Envelope Protein gp120 / immunology*
  • HIV-1 / immunology*
  • Macaca mulatta
  • Mice
  • Mice, Inbred BALB C
  • Microscopy, Electron
  • Neutralization Tests
  • Rabbits
  • Radioimmunoassay

Substances

  • Adjuvants, Immunologic
  • HIV Antibodies
  • HIV Envelope Protein gp120